Regulation of Retinal Physiology by micro-RNAs
Regulation of Retinal Physiology by micro-RNAs
批准号:
8431587
负责人:
Krzysztof Palczewski
金额:
$35.55万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-01 至 2018-02-28
关键词:
AdultAlgorithmsAnatomyAnimalsBase PairingBiochemicalBioinformaticsCell DeathCellsCessation of lifeDataDegenerative DisorderDevelopmentDiseaseDisease modelEventExhibitsExposure toEyeGene ClusterGene ExpressionGene Expression ProfileGene Expression RegulationGene TargetingGenesHealthImmunoprecipitationInvestigationKnockout MiceLightLinkMeasuresMediatingMessenger RNAMicroRNAsMitoticMolecularMusOpen Reading FramesOrganPathologyPathway interactionsPhenotypePhotoreceptorsPhysiologicalPhysiological ProcessesPhysiologyPlantsPlayPoriferaProtein BiosynthesisProteinsRNARNA BindingRNA-Binding ProteinsRNA-Induced Silencing ComplexRegulationRepressionResidual stateRetinaRetinalRetinal DegenerationRetinitis PigmentosaRoleSeedsSensorySiteStressTechniquesTechnologyTissuesTranslational RepressionTranslationsVisual system structurebasecrosslinkin vivoinsightinterestloss of functionmouse modelnew technologynext generation sequencingnovelnovel strategiesparalogous genepreventpublic health relevanceresearch studytreatment strategyvision development
中文摘要
描述(由申请人提供):微小RNA(miRNA)是小的、稳定的RNA分子,在植物和动物中转录后调节基因表达。它们通过与靶信使RNA上的部分互补序列进行碱基配对来抑制蛋白质合成,主要通过翻译抑制和mRNA去稳定化。据报道,超过250种miRNA在视网膜中表达,并且miRNA基因调控已显示影响视网膜发育、功能和疾病。miR-96、-183和-182包含进化上保守的旁系同源基因簇。光感受器中这些miRNAs活性的同时部分破坏导致稳健的光诱导视网膜变性表型,这意味着这些miRNAs在暴露于光期间起到神经保护功能。因此,这种miRNA介导的感光细胞存活途径是视网膜退行性疾病潜在治疗的新靶点。为了更直接地评估miR-183簇在视网膜变性疾病背景下对光感受器存活的影响,
将在常染色体显性和常染色体隐性视网膜色素变性的新小鼠模型中评估miR-183簇功能丧失的后果。将产生敲除小鼠模型以确定miRNA簇活性完全丧失的影响。此外,将采用“自上而下”和“自下而上”方法的组合来剖析miRNA介导的感光细胞保护的分子事件。新开发的生物化学技术将用于识别视网膜中这些miRNA的功能相关直接靶点,下一代测序技术将用于评估暴露于强光后发生的miRNA簇依赖性基因表达改变。这些研究的结果将提供深入了解基因调控网络参与保护光感受器免受压力诱导的死亡。这些实验有望产生治疗或预防致盲疾病的新方法。
英文摘要
DESCRIPTION (provided by applicant): Micro-RNAs (miRNAs) are small, stable RNA molecules that post-transcriptionally regulate gene expression in plants and animals. They act by base pairing to partially complementary sequences on target messenger RNAs to inhibit protein synthesis, primarily through translational repression and mRNA destabilization. More than 250 miRNAs are reportedly expressed in the retina, and miRNA gene regulation has been shown to impact retinal development, function, and disease. miRs -96, -183, and -182 comprise an evolutionarily conserved, paralogous gene cluster. Simultaneous partial disruption of the activities of these miRNAs in photoreceptors results in a robust light-induced retinal degeneration phenotype, implying that these miRNAs serve a neuroprotective function during exposure to light. Thus, this miRNA-mediated photoreceptor survival pathway is a novel target for potential therapy of retinal degenerative disorders. To evaluate the impact of the miR-183 cluster on photoreceptor survival more directly in the context of retinal degenerative disease, the
consequences of miR-183 cluster loss-of-function will be evaluated in new mouse models of autosomal dominant and autosomal recessive retinitis pigmentosa. A knockout mouse model will be generated to determine the impact of complete loss of miRNA cluster activity. Additionally, a combination of 'top-down' and 'bottom-up' approaches will be employed to dissect out the molecular events underlying miRNA-mediated photoreceptor protection. Newly developed biochemical techniques will be used to identify functionally relevant direct targets of these miRNAs in the retina, and next generation sequencing technology will be employed to evaluate miRNA cluster-dependent alterations in gene expression that occur after exposure to intense light. Results of these investigations will provide insights into gene regulation networks involved in protecting photoreceptors against stress-induced death. These experiments promise to yield novel approaches to treat or prevent blinding diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Precision genome editing in vivo to treat retinal diseases
-
批准号:10565189
-
项目类别:
-
资助金额:$60.23万
-
财政年份:2023
-
负责人:Krzysztof Palczewski
-
依托单位:
Visual Sciences Training Program (VSTP)
-
批准号:10410300
-
项目类别:
-
资助金额:$9.6万
-
财政年份:2022
-
负责人:Krzysztof Palczewski
-
依托单位:
Visual Sciences Training Program (VSTP)
-
批准号:10615907
-
项目类别:
-
资助金额:$9.86万
-
财政年份:2022
-
负责人:Krzysztof Palczewski
-
依托单位:
The complex role of phosphodiesterase 6 in rod photoreceptor health and function
-
批准号:10662478
-
项目类别:
-
资助金额:$62.95万
-
财政年份:2020
-
负责人:Krzysztof Palczewski
-
依托单位:
The complex role of phosphodiesterase 6 in rod photoreceptor health and function
-
批准号:10455528
-
项目类别:
-
资助金额:$63.34万
-
财政年份:2020
-
负责人:Krzysztof Palczewski
-
依托单位:
Visual Sciences Training Program
-
批准号:9280013
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2017
-
负责人:Krzysztof Palczewski
-
依托单位:
Use of systems pharmacology to prevent rod and cone photoreceptor degeneration
-
批准号:9554184
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2017
-
负责人:Krzysztof Palczewski
-
依托单位:
A two-photon ophthalmoscope for human retinal imaging and functional testing
-
批准号:9059094
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2015
-
负责人:Krzysztof Palczewski
-
依托单位:
Regulation of Retinal Physiology by micro-RNAs
-
批准号:8627170
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2013
-
负责人:Krzysztof Palczewski
-
依托单位:
Photoreceptor Renewal by Retinal Pigmented Epithelium Phagocytosis
-
批准号:8330430
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2012
-
负责人:Krzysztof Palczewski
-
依托单位:
Photoreceptor Renewal by Retinal Pigmented Epithelium Phagocytosis
-
批准号:8700414
-
项目类别:
-
资助金额:$30.77万
-
财政年份:2012
-
负责人:Krzysztof Palczewski
-
依托单位:
Photoreceptor Renewal by Retinal Pigmented Epithelium Phagocytosis
-
批准号:8511669
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2012
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8538634
-
项目类别:
-
资助金额:$198.36万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8018234
-
项目类别:
-
资助金额:$193.1万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8540429
-
项目类别:
-
资助金额:$196.27万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8149852
-
项目类别:
-
资助金额:$196.27万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8733836
-
项目类别:
-
资助金额:$102.5万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
STRUCTURAL STUDIES OF G PROTEIN-COUPLED RECEPTORS
-
批准号:8000206
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8326704
-
项目类别:
-
资助金额:$196.27万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
Pharmacological Treatment of Retinal Diseases
-
批准号:8728864
-
项目类别:
-
资助金额:$196.27万
-
财政年份:2010
-
负责人:Krzysztof Palczewski
-
依托单位:
海外基金